Molecular Devices Stock Plunges 19 Percent on Lackluster Drug-discovery Product Sales, Net Loss | GenomeWeb

NEW YORK, Oct. 29 (GenomeWeb News) - Investors continued to spank Molecular Devices today after the company posted a net loss and warned of the future of its drug-discovery product lines yesterday, even though it posted a 42-percent surge in total revenue.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.